| Literature DB >> 28063458 |
Kensuke Minami1,2, Tsuneaki Kenzaka3,4, Ayako Kumabe1, Masami Matsumura1.
Abstract
BACKGROUND: Pyomyositis is typically caused by Staphylococcus aureus, and is rare in temperate climates, although its prevalence has been recently increasing. This infection often involves the thigh, and is associated with immunodeficiency. CASEEntities:
Keywords: Group A streptococcus; Immunocompetent adult; Pyomyositis
Mesh:
Substances:
Year: 2017 PMID: 28063458 PMCID: PMC5219714 DOI: 10.1186/s13104-016-2346-2
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Enhanced computed tomography reveals fluid between the dorsal distal muscles of the left thigh and an enhanced margin of fluid (white arrows)
The general clinical features of pyomyositis in temperate and tropical cases
| Temperate cases | Tropical cases | |
|---|---|---|
| Ages [ | Adults (elderly) | Children (2–5 years) and adults (35–40 years) |
| Underlying conditions [ | Immunocompromised or serious underlying conditions, such as HIV infection, diabetes mellitus, leukemia, chronic renal failure, asplenia, scleroderma, rheumatoid arthritis, Felty’s syndrome, chemotherapy, or immunosuppressive treatment | Healthy |
| Microbiology ( | 60–75 | >90 |
| Positive blood cultures [ | 20–30 | 5–10 |
| Mortality [ | 6.0–9.4 | 0.5–2.0 |
Clinical features of group A streptococcus pyomyositis
| Age (years) | Sex | Tropical | Underlying condition | Area of infection | Single or multiple lesions | Blood cultures | ICU stay | Antibiotics | Treatment duration (days) | Drainage | Prognosis | Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | M | No | None | Left thigh | – | Positive | – | 2nd cef, PCG, aminoglycoside | 40 | Surgical | Recovered | [ |
| 2 | M | No | None | Right iliac muscle | Single | Negative | No | – | 21 | No | Recovered | [ |
| 4 | M | No | Autism | Left psoas/thigh | Multiple | Positive | Yes | CTRX, VCM → PCG, CLDM | – | Surgical | Recovered | [ |
| 5 | F | No | None | Right thigh | Single | Negative | No | Oxacillin | – | Surgical | Recovered | [ |
| 8 | M | No | None | Neck | – | – | – | – | – | – | – | [ |
| 9 | M | No | None | Right iliopsoas | Multiple | Positive | No | – | 33 | Surgical | Recovered | [ |
| 17 | M | Yes | – | – | Multiple | Positive | – | – | – | – | Recovered | [ |
| 19 | M | No | None | Right thigh and left knee | Multiple | – | No | PCG | – | Surgical | Recovered | [ |
| 23 | M | Yes | – | Left arm | Single | Negative | – | – | – | – | Recovered | [ |
| 24 | F | No | None | Right neck | Single | Negative | No | CEZ | 28 | Surgical | Recovered | [ |
| 26 | F | No | None | Left thoraco-abdominal muscle | Multiple | Negative | Yes | Ticarcillin-clavulanate → PCG | 7 | Surgical | Recovered | [ |
| 30 | F | No | None | Left hand and both thighs | Multiple | Positive | Yes | CTRX, CLDM | – | – | Recovered | [ |
| 31 | M | Yes | None | Left psoas | – | Negative | – | PCG | – | No | Recovered | [ |
| 33 | F | No | DM | Left axilla | Single | Negative | No | PCG | 20 | Surgical | Recovered | [ |
| 38 | F | No | None | Right shoulder/arm | Multiple | Negative | No | PCG | 11 | Surgical | Recovered | [ |
| 40 | F | No | None | – | Multiple | Positive | – | – | – | – | Died | [ |
| 44 | F | No | None | Left calf/knee | Multiple | – | – | CTX, metro, PCG → PCG | – | Surgical | Recovered | [ |
| 48 | M | No | None | Left neck | Single | Negative | No | Ticarcillin-clavulanate, CLDM → PCG | 28 | Surgical | Recovered | [ |
| 49 | F | No | None | Right arm | – | – | – | PCG | – | – | Died | [ |
| 52 | M | No | None | Left thigh | Single | – | No | Cloxacillin, PCG | 6 | Surgical | Recovered | [ |
| 53 | M | No | None | Left calf | – | Positive | – | PCG, aminoglycoside | – | – | Died | [ |
| 67 | M | No | None | Left thigh | – | – | – | CEZ → PCG | 10 | Surgical | Recovered | [ |
| 76 | M | No | IPF | Right biceps | Single | Positive | Yes | PCG | 31 | Surgical | Recovered | [ |
| – | F | Yes | None | Neck | Single | Positive | No | Flucloxacillin, PCG | – | No | Recovered | [ |
M male; F female; ICU intensive care unit;– not recorded; → switch; 2nd cef second-generation cephalosporin; PCG benzylpenicillin; CTRX ceftriaxone; VCM vancomycin; CLDM clindamycin; CTX cefotaxime; metro, metronidazole; CEZ cefazolin; DM diabetes mellitus; IPF idiopathic pulmonary fibrosis